CR8772A - Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos - Google Patents
Nuevos derivados de indazol e indolona y su uso como productos farmaceuticosInfo
- Publication number
- CR8772A CR8772A CR8772A CR8772A CR8772A CR 8772 A CR8772 A CR 8772A CR 8772 A CR8772 A CR 8772A CR 8772 A CR8772 A CR 8772A CR 8772 A CR8772 A CR 8772A
- Authority
- CR
- Costa Rica
- Prior art keywords
- indolona
- indazol
- pharmaceutical products
- new derivatives
- class
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se refiere a una clase de agonistas de dopamina, mas particularmente una clase de agonistas que son selectivos por D3 frente a D2
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0411810A GB0411810D0 (en) | 2004-05-26 | 2004-05-26 | New indazole and indolone derivatives and their use as pharmaceuticals |
GB0415455A GB0415455D0 (en) | 2004-07-09 | 2004-07-09 | New indazole and indolone derivatives and their use as pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8772A true CR8772A (es) | 2006-12-13 |
Family
ID=35219654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8772A CR8772A (es) | 2004-05-26 | 2006-11-24 | Nuevos derivados de indazol e indolona y su uso como productos farmaceuticos |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1753763B1 (es) |
JP (2) | JP4093588B2 (es) |
AP (1) | AP2006003823A0 (es) |
AR (1) | AR049191A1 (es) |
AT (1) | ATE404560T1 (es) |
AU (1) | AU2005247696A1 (es) |
BR (1) | BRPI0511533A (es) |
CA (1) | CA2568050A1 (es) |
CR (1) | CR8772A (es) |
DE (1) | DE602005008954D1 (es) |
EA (1) | EA200601985A1 (es) |
EC (1) | ECSP067024A (es) |
ES (1) | ES2308492T3 (es) |
GT (1) | GT200500118A (es) |
IL (1) | IL179365A0 (es) |
MA (1) | MA28606B1 (es) |
MX (1) | MXPA06013759A (es) |
NL (1) | NL1029128C2 (es) |
NO (1) | NO20065328L (es) |
PA (1) | PA8635001A1 (es) |
PE (1) | PE20060289A1 (es) |
SV (1) | SV2005002128A (es) |
TW (1) | TW200607500A (es) |
UY (1) | UY28918A1 (es) |
WO (1) | WO2005116027A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO2860B1 (en) | 2009-05-07 | 2015-03-15 | ايلي ليلي اند كومباني | Phenylendazolyl compounds |
JP6023082B2 (ja) * | 2011-01-24 | 2016-11-09 | インセプタム リサーチ アンド セラピューティクス,インク. | 精神神経性の疾病を処置するためのプロスタグランジンを含む組成物 |
CA2965741C (en) * | 2014-11-03 | 2022-05-17 | Iomet Pharma Ltd | Pharmaceutical compound |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4312593A (en) * | 1992-05-18 | 1993-12-13 | Smithkline Beecham Plc | Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease |
WO1998035942A1 (en) * | 1997-02-18 | 1998-08-20 | American Home Products Corporation | 4-aminoethoxyindazole derivatives |
GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
JP3889775B2 (ja) * | 2002-12-10 | 2007-03-07 | ファイザー・インク | I.a.性機能障害の治療においてドパミンアゴニストとして使用するためのモルホリン誘導体 |
-
2005
- 2005-05-17 MX MXPA06013759A patent/MXPA06013759A/es unknown
- 2005-05-17 BR BRPI0511533-7A patent/BRPI0511533A/pt not_active IP Right Cessation
- 2005-05-17 AP AP2006003823A patent/AP2006003823A0/xx unknown
- 2005-05-17 ES ES05742759T patent/ES2308492T3/es active Active
- 2005-05-17 WO PCT/IB2005/001513 patent/WO2005116027A2/en active IP Right Grant
- 2005-05-17 JP JP2007514182A patent/JP4093588B2/ja not_active Expired - Fee Related
- 2005-05-17 AT AT05742759T patent/ATE404560T1/de not_active IP Right Cessation
- 2005-05-17 EA EA200601985A patent/EA200601985A1/ru unknown
- 2005-05-17 CA CA002568050A patent/CA2568050A1/en not_active Abandoned
- 2005-05-17 EP EP05742759A patent/EP1753763B1/en active Active
- 2005-05-17 DE DE602005008954T patent/DE602005008954D1/de not_active Expired - Fee Related
- 2005-05-17 AU AU2005247696A patent/AU2005247696A1/en not_active Abandoned
- 2005-05-20 GT GT200500118A patent/GT200500118A/es unknown
- 2005-05-23 PE PE2005000570A patent/PE20060289A1/es not_active Application Discontinuation
- 2005-05-24 AR ARP050102145A patent/AR049191A1/es unknown
- 2005-05-24 UY UY28918A patent/UY28918A1/es not_active Application Discontinuation
- 2005-05-25 NL NL1029128A patent/NL1029128C2/nl not_active IP Right Cessation
- 2005-05-25 TW TW094117076A patent/TW200607500A/zh unknown
- 2005-05-26 SV SV2005002128A patent/SV2005002128A/es not_active Application Discontinuation
- 2005-05-26 PA PA20058635001A patent/PA8635001A1/es unknown
-
2006
- 2006-11-16 IL IL179365A patent/IL179365A0/en unknown
- 2006-11-20 NO NO20065328A patent/NO20065328L/no unknown
- 2006-11-24 MA MA29487A patent/MA28606B1/fr unknown
- 2006-11-24 EC EC2006007024A patent/ECSP067024A/es unknown
- 2006-11-24 CR CR8772A patent/CR8772A/es unknown
-
2007
- 2007-12-11 JP JP2007320093A patent/JP2008074874A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PE20060289A1 (es) | 2006-04-22 |
GT200500118A (es) | 2006-01-10 |
NO20065328L (no) | 2006-12-18 |
MA28606B1 (fr) | 2007-05-02 |
WO2005116027A2 (en) | 2005-12-08 |
ES2308492T3 (es) | 2008-12-01 |
BRPI0511533A (pt) | 2008-01-02 |
TW200607500A (en) | 2006-03-01 |
JP2008074874A (ja) | 2008-04-03 |
ATE404560T1 (de) | 2008-08-15 |
PA8635001A1 (es) | 2006-05-16 |
DE602005008954D1 (de) | 2008-09-25 |
IL179365A0 (en) | 2007-03-08 |
CA2568050A1 (en) | 2005-12-08 |
WO2005116027A3 (en) | 2006-04-13 |
EA200601985A1 (ru) | 2007-04-27 |
JP2008500329A (ja) | 2008-01-10 |
ECSP067024A (es) | 2006-12-29 |
MXPA06013759A (es) | 2007-02-08 |
NL1029128C2 (nl) | 2006-06-14 |
SV2005002128A (es) | 2005-12-13 |
EP1753763B1 (en) | 2008-08-13 |
AU2005247696A1 (en) | 2005-12-08 |
NL1029128A1 (nl) | 2005-11-30 |
EP1753763A2 (en) | 2007-02-21 |
AR049191A1 (es) | 2006-07-05 |
JP4093588B2 (ja) | 2008-06-04 |
AP2006003823A0 (en) | 2006-12-31 |
UY28918A1 (es) | 2005-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI200800217A (es) | Arildihidroisoquinolinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos. | |
UY30709A1 (es) | Nuevos derivados de 1,4-benzotiepina-1, 1-dioxido sustituidos con radicales bencilo, método para su preparacion, productos farmacéuticos que comprenden estos compuestos y su uso. | |
CR9695A (es) | Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta y su aplicacion en terapeutica. | |
CL2008002538A1 (es) | Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral | |
HN2006007884A (es) | Derivados de oxiindol | |
CL2008002539A1 (es) | Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral | |
DOP2007000016A (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina. | |
SV2009002858A (es) | Nueva forma polimorfica y la forma amorfa de 5- cloro-n-([(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il]-metil)-2-tiofenocarboxamida | |
ECSP10010627A (es) | Derivados de quinolinas y quinoxalinas como inhibidores de cinasa de proteina tirosina | |
SV2010003751A (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
HN2007000437A (es) | Compuestos de pirazolina y su uso y composiciones farmaceuticas | |
NI201000005A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico. | |
SV2009003299A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa | |
CL2008001815A1 (es) | Compuestos derivados de indazol; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar cancer. | |
CO6210786A2 (es) | Implemento de cuidado oral que alberga un agente de cuidado oral | |
PA8623501A1 (es) | Modulares de receptores de androgenos | |
UY31456A1 (es) | Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos | |
UY30165A1 (es) | Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos | |
UY30163A1 (es) | Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos | |
AR081670A1 (es) | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo | |
ME01459B (me) | Postupak za doziranje medikamenata | |
GT200500357A (es) | Indazoles substituidos, composicones que los comprenden, procedimiento de su preparacion y utilizacion | |
UY30164A1 (es) | Nuevas ariltienopirimidinonas sustituidas con aminoalcoholes, procedimiento para su preparación y su uso como medicamentos | |
UY31788A (es) | Formulación farmacéutica sólida con liberación retardada | |
UY30534A1 (es) | Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapéutica como antagonistas de los receptores de urotensina ii |